Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Development of an Angiogenic Gene Therapy Product for Coronary Artery Disease.

Proposed period of release:
01/02/2003 to 31/07/2003

Name of the Institute(s) or Company(ies)
Schering Espana SA, ;

3. Is the same GMO release planned elsewhere in the Community?
Not known

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus: Mastadenovirus
Species: human Adenovirus

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
human serotype 5 (Ad5)Mastadenovirushuman adenovirussubgroup Chuman serotype 5 (Ad5)

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known